bioRxiv · 10.1101/2020.09.10.292318
A COVID-19 antibody curbs SARS-CoV-2 nucleocapsid protein-induced complement hyper-activation
Abstract
Although human antibodies elicited by severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) nucleocapsid (N) protein are profoundly boosted upon infection, little is known about the function of N-directed antibodies. Herein, we isolated and profiled a panel of 32 N protein-specific monoclonal antibodies (mAb) from a quick recovery coronavirus disease-19 (COVID-19) convalescent, who had dominant antibody responses to SARS-CoV-2 N protein rather than to Spike protein. The complex structure of N protein RNA binding domain with the highest binding affinity mAb nCoV396 reveals the epitopes and antigens allosteric changes. Functionally, a virus-free complement hyper-activation analysis demonstrates that nCoV396 specifically compromises N protein-induced complement hyper-activation, a risk factor for morbidity and mortality in COVID-19, thus paving the way for functional anti-N mAbs identification. One Sentence SummaryB cell profiling, structural determination, and protease activity assays identify a functional antibody to N protein.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kang, S., Yang, M., He, S., Wang, Y., Chen, X., Chen, Y., Hong, Z., Liu, J., Jiang, G., Chen, Q., Zhou, Z., Huang, Z., Huang, X., He, H., Zheng, W., Liao, H.-X., Xiao, F., Shan, H., Chen, S.. 2020-09-11. A COVID-19 antibody curbs SARS-CoV-2 nucleocapsid protein-induced complement hyper-activation. https://doi.org/10.1101/2020.09.10.292318
Cite the original work for its findings. Save a collection to share your selection of sources.